New FDA-approved drug offers hope for pancreatic cancer patients
New FDA-approved drug offers hope for pancreatic cancer patients

New FDA-approved drug offers hope for pancreatic cancer patients

Northwestern Medicine oncologist Dr. Deva Mahalingam discusses a newly approved pancreatic cancer drug, how it differs from traditional chemotherapy and what it could mean for patients.

Chicago Area News

Good Day Chicago

FOX 32 Sports